Somerset Indus Capital Partners 
Dealstreet

ELP advises Somerset Indus Capital Partners in its investment in Natural Biogenex

The investment amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Natural Biogenex Private Limited, a company manufacturing steroidal APIs.

This marks the fund’s sixth overall investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this investment.

The transaction team consisted of Vinay Butani (Partner), Rudraksh Bhatt (Senior Associate) and Faiz Thakur (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Karnataka High Court stays BJP's defamation case against CM Siddaramaiah over 'corruption rate' ads

Supreme Court Justice Surya Kant defends India's human rights record

Supporting Pakistan sans mention of India not an offence under Section 152 BNS: Allahabad High Court

S&R Associates, ELP act on Sambhv Steel Tubes ₹540 crore IPO

Dhrupad Vaghani launches full-service law firm Anchorstone Legal

SCROLL FOR NEXT